Skip to content
VivoSense, Inc. logo — Advancing clinical trials research and healthcare delivery w...

VivoSense, Inc.

Advancing clinical trials research and healthcare delivery with analytics & AI for all wearable sensor data, ePRO/eCOA

Founded 2010 United States United States 42 employees Grant Total: $27.00M Biotechnology, Health Care +1

General Information

Company Name VivoSense, Inc.
Founded Year 2010
Location United States United States
Employees 42
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with VivoSense, Inc.. To contact VivoSense, Inc., visit vivosense.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does VivoSense, Inc. compare?

A PDF of VivoSense, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting VivoSense, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About VivoSense, Inc.

VivoSense, Inc. is a pioneering company in the field of data analysis consulting and software, focusing on wearable sensor physiological monitoring solutions for clinical trials, healthcare research, and consumer wellness. Established in 2010 and headquartered in the United States, VivoSense has made significant strides in the development of regulatory compliant digital biomarkers utilizing data from wearable sensors. These digital biomarkers play a crucial role in accurately measuring drug and treatment effects in regulated clinical trials and healthcare research. What sets VivoSense apart is its distinction as the first analytics company to devise novel digital biomarkers from wearable sensor data, which are integral in regulated international pharmaceutical trials as primary and secondary clinical endpoints. Notably, the company has managed to advance numerous studies in rare disease indications, reaching the open-label phase of development at top-ten pharma. The most recent grant investment received by VivoSense, Inc. was on 19 January 2023, facilitated by MassAITC and the National Institute on Aging. This further underscores the company's potential and the significance of its contributions to the healthcare and biotechnology industries.

Business keywords: Clinical Trials, Healthcare Research, Wearable Sensors, ePRO, eCOA, Digital Biomarkers, Rare Disease Indication, Pharmaceutical Trials, Data Analysis Consulting, Physiological Monitoring, Consumer Wellness

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 2
MassAITC, National Institute on Aging
19 Jan 2023
Series A $25.00M 2
Debiopharm Innovation Fund, Perceptive Advisors
30 Mar 2022
Venture Round $2.00M -
29 May 2019

VivoSense, Inc. Alternatives & Competitors

View All Alternatives
VivoSense, Inc. vs

A boutique CRO that simplifies data collection, data management, statistical analysis and reporting...

19 employees
Biotechnology, Data Analytics
VivoSense, Inc. vs

Biochemical Sensors for a Better World

Pre-Seed
6 employees
Biotechnology, Health Care
VivoSense, Inc. vs
Medable
Medable United States

Leading the technology revolution in clinical development.

Series D
359 employees
Health Care, Medical Devices

FAQ About VivoSense, Inc.

Advancing clinical trials research and healthcare delivery with analytics & AI for all wearable sensor data, ePRO/eCOA
VivoSense, Inc. was founded in 2010.
VivoSense, Inc. is headquartered in United States.
VivoSense, Inc. operates in Biotechnology, Health Care and Medical Devices. Its work centres on Clinical Trials, Healthcare Research, Wearable Sensors and ePRO.
VivoSense, Inc. has approximately 42 employees.
VivoSense, Inc. has completed 3 funding rounds, raising a total of $27.00M. The latest funding stage is Grant.
Top alternatives and competitors to VivoSense, Inc. include Resolutum Global Pty Ltd, EOXsense, Medable, OptiChroniX, BIOSerenity. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VivoSense, Inc. and Resolutum Global Pty Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for VivoSense, Inc., https://bouncewatch.com/company/vivosense-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout